Stephen Feig’s Tips on Building an Anti-Inflammatory Lifestyle Backed by Clinical Evidence

Image source: Unsplash.

Inflammation can be a natural defense mechanism that helps the body heal after injury or infection. While short-term, or acute, inflammation plays a protective role, chronic inflammation can silently damage tissues and organs over time. Chronic inflammation has been linked to the development and progression of numerous conditions, including heart disease, type 2 diabetes, depression, memory loss, aging, and arthritis. It often goes unnoticed for years, gradually wearing down bodily systems. Recognizing this connection allows individuals to make informed lifestyle shifts grounded in science. Dr. Stephen Feig reminds us that inflammation isn’t just swollen joints or the presence of a major illness —healthy individuals may also be affected without realizing it.

Dr. Feig notes that modern medicine excels at treating disease once it becomes clinically visible. We restore blood flow in coronary arteries, regulate glucose in diabetes, and suppress immune activity in autoimmune disease. Yet the total burden of chronic illness continues to rise. Cardiovascular disease, diabetes and metabolic dysfunction, and neurodegeneration remain dominant drivers of impaired health, mortality, and medical cost. This trajectory reflects a structural mismatch: healthcare targets late-stage manifestations of illness while the underlying biology begins shifting years earlier. That biology is increasingly clear. Chronic, low-grade inflammation acts as a central driver of disease development—shaping risk long before conventional diagnosis takes place.

Mood, Memory and Inflammation

Chronic inflammation does not only affect the body—it also influences the brain, particularly areas involved in mood and memory. Inflammatory signals can cross into the brain or alter neurotransmitter systems, reducing the availability of chemicals like serotonin and dopamine that regulate mood. At the same time, inflammation can disrupt the hippocampus, a key structure for learning and memory formation, leading to difficulties with focus, recall, and mental clarity. Over time, sustained inflammatory activity has been linked to increased risk of depression, cognitive decline, and neurodegenerative conditions, highlighting the close connection between low level inflammation and brain function.

Inflammation As A New Primary Target of Disease Prevention

Inflammation is not just a short-term reaction—it represents a long-term shift in how the body’s immune and metabolic systems are functioning. Instead of turning on briefly and shutting off, the inflammatory pathways stay partially activated, continuously releasing signals that affect processes like energy use, blood vessel function, memory, mood, and hormone balance. Over time, this sustained activation can slowly reshape how the body operates, increasing the risk of chronic diseases, often without obvious symptoms. This shift is measurable through a set of biomarkers that capture different layers of inflammatory activity, including: IL‑6 (upstream signaling), hs‑CRP (systemic burden), Lp-PLA2 (arterial inflammation), MPO (vascular injury), SAA (early response), and GlycA (chronic system-wide inflammation).

Together, these markers provide a multidimensional view—from initiation to long-term inflammatory burden—that traditional testing alone cannot capture. Large-scale cohort data show that multi-marker inflammatory panels improve cardiovascular risk prediction beyond cholesterol and blood pressure alone. Mechanistically, this is reflected across disease states: inflammation destabilizes arterial plaques, disrupts insulin signaling, and accelerates neurodegeneration. Clinical consensus now reflects this shift. The American College of Cardiology recognizes inflammation as a causal and actionable driver of cardiovascular disease.

A System Built for Late Detection

Conventional healthcare typically identifies disease after structural damage becomes measurable. For example, structural changes in the walls of arteries can contribute to high blood pressure. This illness typically is discovered once blood pressure rises and not in the early stages of inflammatory changes within the cells that line the arteries. Inflammatory signaling develops earlier than symptoms and often remains subclinical. Longitudinal studies show that individuals with elevated inflammatory burden face significantly higher long-term cardiovascular risk—even without baseline disease. For example, by the time glucose rises or plaque forms, immune signaling has already altered vascular, metabolic, and cellular systems. Conventional treatment usually targets outcomes while upstream inflammatory drivers remain active.

Closing the Measurement Gap: What We’re Not Testing

One reason inflammation remains underprioritized is that it is under-measured. Most clinical care relies on a single marker—C-reactive protein (CRP). While useful, CRP captures only a fraction of the inflammatory system. Inflammation operates across multiple pathways, and newer biomarkers provide clearer, earlier insight into risk. Several of these markers are already available through major labs—but are rarely used in routine care.:

• GlycA: A marker that reflects chronic, system-wide inflammation by measuring multiple inflammatory proteins simultaneously. GlycA has been shown to predict cardiovascular disease, diabetes, and mortality risk independently of CRP. It is not yet widely available in standard lab panels but represents one of the most promising tools for capturing long-term inflammatory burden.

• Interleukin-6 (IL‑6): Measures active inflammatory signaling at its source. Elevated IL‑6 predicts cardiovascular events, insulin resistance, and mortality, often earlier than CRP.

• Lp-PLA2: Identifies inflammation within arterial plaques and helps determine which plaques are most likely to rupture—directly linking inflammation to heart attack and stroke risk.

• Myeloperoxidase (MPO): An enzyme released by activated white blood cells that reflects oxidative stress and vascular inflammation. Elevated MPO levels are associated with plaque instability and increased risk of cardiovascular events, even when traditional markers appear normal.

• Serum Amyloid A (SAA): Responds rapidly to inflammation and can detect low-grade or early inflammatory activity that CRP may miss.

• hs-CRP: A useful baseline marker but functions best when interpreted alongside more targeted measures.

The limitation in modern care is not a lack of tools—it’s that we don’t fully use the ones we already have. Many of the tests and insights needed to understand inflammation exist today but are not consistently applied in routine care. Looking at a broader set of inflammatory markers provides a more accurate picture of what’s happening in the body and aligns much more closely with how disease actually develops over time.

Nutrition as a Primary Control System

Food directly regulates inflammatory biology through immune, metabolic, and microbiome pathways.

Dietary Patterns

A 2025 meta-analysis of 33 randomized controlled trials found that Mediterranean-style diets significantly reduce CRP, IL‑6, and other inflammatory biomarkers linked to chronic disease progression. This dietary pattern emphasizes whole, minimally processed foods—particularly vegetables, fruits, legumes, whole grains, nuts, and seeds—paired with healthy fats like extra-virgin olive oil and regular intake of fish. It also limits refined sugars, processed foods, and excessive red meat, creating a consistent anti-inflammatory environment at the cellular level.

Plant-based dietary patterns show similarly strong signals. A 2026 systematic review of randomized trials found that vegan, vegetarian, and whole-food plant-based diets reduced CRP by an average of 1.13 mg/L—a magnitude large enough to shift cardiovascular risk categories. A separate 2025 meta-analysis of 65 studies found that vegetarian diets significantly reduce CRP levels compared to omnivorous diets, indicating lower systemic inflammation across populations. These results reflect a consistent biological pattern: plant-forward diets lower inflammatory tone at the system level.

Mechanisms: Why Plant-Based Diets Reduce Inflammation

The anti-inflammatory effects of plant-based diets operate through several converging mechanisms:

• Fiber-driven microbiome modulation: High fiber intake increases the production of short-chain fatty acids, which help regulate immune responses and suppress inflammatory signaling
• Lower intake of saturated fats: Reduced consumption of animal-derived fats limits substrates that drive inflammatory pathways
• Polyphenol activity: Plant compounds influence gene expression and reduce oxidative stress, both of which are tied to inflammation

Human data support these mechanisms. Higher intake of plant-based protein and fiber is associated with lower CRP levels and improved immune signaling. Clinical trials also show that plant-based diets increase beneficial microbial diversity and reduce markers of intestinal inflammation.

Together, this establishes a clear biological sequence: diet → microbiome → metabolites → immune signaling → inflammation → disease

Ultra-Processed Foods

Ultra-processed foods act as a steady source of physiological stress, keeping the immune response partially activated over time. Unlike whole foods, they lack key nutrients—such as fiber, antioxidants, omega‑3 fatty acids, and polyphenols—that help regulate inflammation. Patterns built around refined grains, packaged snacks, fast food, and sugary beverages disrupt the gut microbiome, increase oxidative stress, and promote immune activation. Over time, these effects raise baseline inflammation levels, making diet quality a primary determinant of inflammatory load.

Polyphenols and Bioactive Compounds

Polyphenols—found in foods like berries, olive oil, tea, and dark chocolate—directly influence inflammatory pathways by reducing oxidative stress and supporting beneficial gut bacteria. Clinical evidence shows consistent reductions in markers such as IL‑6 with polyphenol-rich diets. Whole-food sources tend to produce stronger effects than isolated supplements, likely due to synergistic interactions within the food matrix and the microbiome.

Omega-3 Fatty Acids

Omega-3 fatty acids (EPA and DHA) provide targeted anti-inflammatory effects. Clinical trials and meta-analyses show reductions in CRP, IL‑6, and TNF‑α, particularly in individuals with higher baseline inflammation and when adequate dosing is maintained. These fats are most effectively obtained through regular consumption of fatty fish such as salmon, sardines, mackerel, and anchovies, which provide highly bioavailable EPA and DHA. For those who do not consume fish, high-quality fish oil or algae-based supplements can offer an alternative, especially when taken consistently and at appropriate doses.

The Microbiome as an Inflammatory Gatekeeper

The gut microbiome acts as a central regulator of inflammatory signaling. This community of trillions of bacteria living in the digestive tract responds directly to what we eat, and in turn helps shape how the inflammatory system of the body behaves. Dietary patterns influence which bacteria thrive, determining whether the body produces more pro-inflammatory compounds or beneficial metabolites such as short-chain fatty acids that help calm inflammatory activity. Multi-omic studies show that microbiome profiles can predict cardiometabolic outcomes and play a key role in translating diet into inflammation, positioning the microbiome as a direct link between food and overall immune function.

Low-fiber, highly processed diets—built around refined grains, packaged foods, and sugary beverages—reduce microbial diversity and shift the system toward pro-inflammatory signaling. In contrast, diets rich in plant-based fibers (vegetables, fruits, legumes, whole grains, nuts, and seeds) and polyphenol-rich foods (berries, olive oil, tea, coffee, and spices) promote beneficial bacteria, strengthen gut barrier function, and stabilize inflammatory and immune responses.

Over time, these microbiome-driven effects influence not only inflammatory status and cardiometabolic health, but also the trajectory of aging itself—reinforcing diet’s role as a primary regulator of long-term biological resilience.

Movement, Sleep, and Stress: Coordinated Biological Signals

The body is constantly adjusting its inflammatory state based on how we move, rest, and respond to stress. Exercise lowers inflammatory markers such as CRP, IL‑6, and TNF‑α by improving metabolism and reducing excess body fat. Sleep helps regulate immune signals and allows the body to reset; when sleep is poor or inconsistent, inflammatory markers tend to rise. Chronic stress keeps the body in a heightened state of alert, activating hormonal pathways that sustain inflammation over time. Together, these factors function like continuous signals feeding into the same system—either helping calm inflammation or keeping it elevated depending on daily habits.

The Shift to System Management

Healthcare is shifting toward a model that focuses on managing how the body’s systems function over time, rather than just treating disease after it appears. An inflammation-centered approach focuses on identifying imbalances earlier, before they turn into disease. It expands testing to look beyond standard labs, uses diet and lifestyle patterns that help keep inflammation in check, and considers the role of the gut microbiome in shaping overall health. It also allows for more personalized strategies—like targeted nutrition or supplements—and tracks how the body responds over time. Taken together, this approach aligns care with how disease actually develops, focusing on maintaining balance rather than reacting after problems appear.

The Bottom Line

The scientific evidence now converges across disciplines, from cardiology to neuroscience to metabolic research. Taken together, these findings show that inflammation plays a central role in driving cardiovascular disease, metabolic dysfunction, and neurodegeneration through biological pathways that are both measurable and modifiable. Advances in biomarker testing allow these changes to be detected earlier—often before symptoms appear—making inflammation one of the most actionable targets for preventing disease rather than simply treating it after it develops.

Dietary patterns—particularly plant-forward and Mediterranean models—demonstrate consistent, experimentally validated reductions in inflammatory biomarkers. These patterns emphasize whole, minimally processed foods such as vegetables, fruits, legumes, whole grains, healthy fats like olive oil, and moderate amounts of fish. Microbiome science helps explain why they work, showing how these foods support beneficial gut bacteria and anti-inflammatory signaling. Lifestyle factors such as movement, sleep, and stress management reinforce these effects.

Healthcare systems that prioritize inflammation will detect risk earlier, intervene more precisely, and alter disease trajectories more effectively. The question is no longer whether inflammation matters. The question is why it remains secondary in a system built to manage the consequences it creates.